Results     14-Aug-26
Analysis
Relaxo Footwears
OP up 8.83%
On standalone basis

Quarter ended June 2026 compared with Quarter ended June 2025.

Net sales (including other operating income) of Relaxo Footwears has increased 7.73% to Rs 705.05 crore.  Operating profit margin has jumped from 15.20% to 15.35%, leading to 8.83% rise in operating profit to Rs 108.23 crore.  Raw material cost as a % of total sales (net of stock adjustments) increased from 36.74% to 38.73%.   Purchase of finished goods cost fell from 3.27% to 2.83%.   Employee cost decreased from 15.64% to 15.36%.   Other expenses rose from 29.61% to 29.62%.   

Other income up 14.49% to Rs 12.96 crore.  PBIDT rose 9.41% to Rs 121.19 crore.  Provision for interest up 13.24% to Rs 5.9 crore.  

PBDT rose 9.22% to Rs 115.29 crore.  Provision for depreciation rose 1.41% to Rs 40.21 crore.  

Profit before tax grew 13.91% to Rs 75.08 crore.  Provision for tax was expense of Rs 20.14 crore, compared to Rs 17.01 crore.  Effective tax rate was 26.82% compared to 25.81%.

Profit after tax rose 12.35% to Rs 54.94 crore.  

Promoters’ stake was 71.27% as of 30 June 2026 ,compared to 71.27% as of 30 June 2025 .  


Full year results analysis

Net sales (including other operating income) of Relaxo Footwears has declined 3.13% to Rs 2,702.16 crore.  Operating profit margin has jumped from 13.69% to 13.84%, leading to 2.10% decline in operating profit to Rs 373.98 crore.  Raw material cost as a % of total sales (net of stock adjustments) decreased from 37.28% to 36.75%.   Purchase of finished goods cost rose from 3.79% to 3.93%.   Employee cost increased from 14.39% to 15.27%.   Other expenses fell from 30.82% to 30.17%.   

Other income up 71.36% to Rs 46.2 crore.  PBIDT rose 2.74% to Rs 420.18 crore.  Provision for interest up 4.16% to Rs 21.52 crore.  Loan funds rose to Rs 232.65 crore as of 31 March 2026 from Rs 212.52 crore as of 31 March 2025.  Inventories declined from Rs 557.59 crore as of 31 March 2025 to Rs 556.72 crore as of 31 March 2026.  Sundry debtors were lower at Rs 298.89 crore as of 31 March 2026 compared to Rs 312.05 crore as of 31 March 2025.  Cash and bank balance declined from Rs 42.06 crore as of 31 March 2025 to Rs 24.19 crore as of 31 March 2026.  Investments rose to Rs 435.82 crore as of 31 March 2026 from Rs 343.01 crore as of 31 March 2025 .  

PBDT rose 2.67% to Rs 398.66 crore.  Provision for depreciation down 0.78% to Rs 157.2 crore.  Fixed assets increased to Rs 1,453.07 crore as of 31 March 2026 from Rs 1,384.44 crore as of 31 March 2025.  Intangible assets declined from Rs 13.67 crore to Rs 8.85 crore.  

Profit before tax grew 5.04% to Rs 241.46 crore.  Provision for tax was expense of Rs 62.19 crore, compared to Rs 59.54 crore.  Effective tax rate was 25.76% compared to 25.90%.

Profit after tax rose 5.25% to Rs 179.27 crore.  

Promoters’ stake was 71.27% as of 31 March 2026 ,compared to 71.27% as of 31 March 2025 .  

Cash flow from operating activities decreased to Rs 348.25 crore for year ended March 2026 from Rs 406.01 crore for year ended March 2025.  Cash flow used in acquiring fixed assets during the year ended March 2026 stood at Rs 137.12 crore, compared to Rs 115.83 crore during the year ended March 2025.  

Other Highlights

The company sold 4.2 crore pairs in Q1 FY27, down 2.3% from 4.3 crore pairs in Q1 FY26.

In Q1 FY27, Average Realization per pair was Rs 166 as compared to Rs 151 in Q1 FY26.


Management Comments :
Mr. Ramesh Kumar Dua, Managing Director said, “We are pleased to report a healthy start to FY27, with Q1 FY27 Revenue, EBITDA and Profit After Tax growing by 7.7%, 8.8% and 12.4% respectively on a year-on-year basis. The quarter was supported by resilient demand across channels, a trusted brand portfolio, our wide distribution network and disciplined execution. Despite an evolving external environment, including elevated raw material prices and geopolitical uncertainties, we maintained healthy operating performance during the quarter. Our continued focus on cost optimization, product mix improvement and operational efficiencies enabled us to deliver steady margin performance. Expansion and strengthening of our retail EBO network is a key strategic priority for us. Alongside the upgradation and modernisation of our existing outlets, we are progressing with our plans to expand our retail footprint, with an ambition to move closer to the 500 store mark by year end. This expansion will help us deepen our reach in regions where our presence is currently limited or underpenetrated, enhance consumer accessibility and create the right retail platform for our premium product portfolio. Looking ahead, we remain optimistic about the demand environment and are focused on sustaining the improvement seen over the last few quarters. Our strong brand portfolio, expanding retail network, continued focus on product innovation and wide distribution position us well to capitalise on growth opportunities and create long-term value for all stakeholders.”



Relaxo Footwears : Standalone Results
Quarter endedYear ended
Particulars202606202506Var.(%)202603202503Var.(%)
Net Sales (including other operating income)705.05654.497.732,702.162,789.61-3.13
OPM (%)15.3515.2016 bps13.8413.6915 bps
OP108.2399.458.83373.98382.00-2.10
Other Inc.12.9611.3214.4946.2026.9671.36
PBIDT121.19110.779.41420.18408.962.74
Interest5.95.2113.2421.5220.664.16
PBDT115.29105.569.22398.66388.302.67
Depreciation40.2139.651.41157.2158.43-0.78
PBT75.0865.9113.91241.46229.875.04
PBT before EO75.0865.9113.91241.46229.875.04
EO Income00-00-
PBT after EO75.0865.9113.91241.46229.875.04
Taxation20.1417.0118.4062.1959.544.45
PAT54.9448.912.35179.27170.335.25
P/(L) from discontinued operations net of tax00-00-
Net profit after discontinued operations54.9448.912.35179.27170.335.25
EPS (Rs)*2.211.9612.357.206.845.25
* EPS is on current equity of Rs 24.89 crore, Face value of Rs 1, Excluding extraordinary items.
# EPS is not annualised
bps : Basis points
EO : Extraordinary items
Figures in Rs crore
Source: Capitaline Corporate Database


Previous News
  Relaxo Footwears
 ( Results - Analysis 13-Nov-25   20:44 )
  Relaxo Footwears surges after Q4 PAT climbs to Rs 68 crore
 ( Hot Pursuit - 29-May-26   11:01 )
  Relaxo Footwears standalone net profit rises 24.90% in the June 2022 quarter
 ( Results - Announcements 26-Jul-22   16:26 )
  Relaxo Footwears to conduct board meeting
 ( Corporate News - 20-May-26   17:32 )
  Relaxo Footwears slides as CFO Prince Jain resigns
 ( Hot Pursuit - 12-Mar-26   09:38 )
  Relaxo Footwears standalone net profit rises 28.14% in the December 2023 quarter
 ( Results - Announcements 31-Jan-24   18:04 )
  Volumes spurt at Relaxo Footwears Ltd counter
 ( Hot Pursuit - 29-May-26   11:00 )
  Supriya Lifescience Ltd leads gainers in 'A' group
 ( Hot Pursuit - 29-May-26   12:00 )
  Relaxo Footwears
 ( Results - Analysis 01-Feb-25   12:30 )
  Board of Relaxo Footwears recommends Final Dividend
 ( Corporate News - 09-May-25   17:17 )
  Relaxo Footwears standalone net profit rises 56.15% in the September 2015 quarter
 ( Results - Announcements 02-Nov-15   08:57 )
Other Stories
  Natco Pharma
  17-Aug-26   17:20
  Ashok Leyland
  17-Aug-26   14:27
  Alkem Laboratories
  17-Aug-26   14:18
  Patanjali Foods
  17-Aug-26   13:54
  Abbott India
  17-Aug-26   13:42
  3M India
  17-Aug-26   13:39
  Bata India
  17-Aug-26   13:25
  Belrise Industries
  17-Aug-26   10:08
  M M Forgings
  17-Aug-26   09:46
  Apeejay Surrendra Park Hotels
  15-Aug-26   06:43
Back Top